IRF4 and neoplasm: First, the exhaustion of CD8+ cells is a common cause of the failure of immunotherapy, and the cooperation of BATF with IRF4 could counter this exhaustion in tumor-infiltrating CAR T-cells (Sopel et al., 2016).